DANIEL HARTMAN: Open Payments
NPI 1497827125 · HUNTINGDON VALLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 10 payments from 8 companies in 2025. Trend: 2023 $1,266 · 2024 $1,327 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: CAPLYTA, INGREZZA, INVEGA SUSTENNA, COBENFY, Jornay PM, Qelbree, Auvelity, VRAYLAR.
Industry payments across PA — which companies pay providers there.
